Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Benjamin

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Cancers|May 11, 2024
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center ExperienceLewis F Nasr, Marianne Zoghbi, Rossana Lazcano, et al.
International Journal of Cancer|February 7, 2022
Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma centerElise F Nassif, Brandon Cope, Raymond Traweek, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 13, 2009
Bone cancer clinical practice guidelinesJ Sybil Biermann, Laurence H Baker, Robert Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2007
Bone cancerJ Sybil Biermann, Douglas Adkins, Robert Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 13, 2009
Soft tissue sarcoma clinical practice guidelines in oncologyGeorge D Demetri, Laurence H Baker, Derrick Beech, et al.
The Lancet. Oncology|August 7, 2022
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trialNeeta Somaiah, Anthony P Conley, Edwin Roger Parra, et al.
Frontiers in Oncology|October 31, 2022
The immune landscape of undifferentiated pleomorphic sarcomaRossana Lazcano, Carmelia M Barreto, Ruth Salazar, et al.
Journal of Cardiac Failure|February 22, 2014
ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons, Michael J Wolk, Steven R Bailey, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 31, 2013
ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic SurgeonsGrace Ronan, Michael J Wolk, Steven R Bailey, et al.
Nature Cancer|February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcomaChristina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Cancers|May 11, 2024
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center ExperienceLewis F Nasr, Marianne Zoghbi, Rossana Lazcano, et al.
International Journal of Cancer|February 7, 2022
Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma centerElise F Nassif, Brandon Cope, Raymond Traweek, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 13, 2009
Bone cancer clinical practice guidelinesJ Sybil Biermann, Laurence H Baker, Robert Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2007
Bone cancerJ Sybil Biermann, Douglas Adkins, Robert Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 13, 2009
Soft tissue sarcoma clinical practice guidelines in oncologyGeorge D Demetri, Laurence H Baker, Derrick Beech, et al.
The Lancet. Oncology|August 7, 2022
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trialNeeta Somaiah, Anthony P Conley, Edwin Roger Parra, et al.
Frontiers in Oncology|October 31, 2022
The immune landscape of undifferentiated pleomorphic sarcomaRossana Lazcano, Carmelia M Barreto, Ruth Salazar, et al.
Journal of Cardiac Failure|February 22, 2014
ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons, Michael J Wolk, Steven R Bailey, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 31, 2013
ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic SurgeonsGrace Ronan, Michael J Wolk, Steven R Bailey, et al.
Nature Cancer|February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcomaChristina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Pageof 9